eprintid: 18663 rev_number: 17 eprint_status: archive userid: 1589 dir: disk0/00/01/86/63 datestamp: 2015-05-26 13:53:46 lastmod: 2024-02-28 03:55:01 status_changed: 2015-05-26 13:53:46 type: article metadata_visibility: show creators_name: Lewis, Matthew D. creators_name: Pfeil, Johannes creators_name: Müller, Ann-Kristin title: Continuous oral chloroquine as a novel route for Plasmodium prophylaxis and cure in experimental murine models subjects: ddc-610 divisions: i-910500 divisions: i-911700 abstract: Background: Chloroquine (CQ) is utilized as both cure and prophylaxis to Plasmodium infection. In animal studies, CQ administration to experimental animals is via intraperitoneal (i.p.) injection of a single dose that varies from daily to several times per week. Such daily administration can be distressing to the animals and provoke aggressive behaviors that may affect the immune responses of the animal and interfere with data read-outs. Findings: We describe a novel, viable and efficacious prophylactic and curative administration route whereby chloroquine is continuously supplied in the drinking water to experimental animals. The prophylactic effect is robust and the curative effect against patent blood stage infection comparable to the traditional route of i.p. administration. Continuous drinking water administration may decrease animal stress responses and thus improve the reliability of experimental data. date: 2011 publisher: Biomed Central id_scheme: DOI ppn_swb: 165704923X own_urn: urn:nbn:de:bsz:16-heidok-186634 language: eng bibsort: LEWISMATTHCONTINUOUS2011 full_text_status: public publication: BMC Research Notes volume: 4 number: 262 place_of_pub: London pagerange: 1-4 issn: 1756-0500 citation: Lewis, Matthew D. ; Pfeil, Johannes ; Müller, Ann-Kristin (2011) Continuous oral chloroquine as a novel route for Plasmodium prophylaxis and cure in experimental murine models. BMC Research Notes, 4 (262). pp. 1-4. ISSN 1756-0500 document_url: https://archiv.ub.uni-heidelberg.de/volltextserver/18663/1/13104_2011_Article_1000.pdf